S&P 500   3,623.63 (-0.32%)
DOW   29,867.15 (-0.60%)
QQQ   295.60 (+0.38%)
AAPL   116.23 (+0.92%)
MSFT   213.63 (-0.11%)
FB   274.61 (-0.83%)
GOOGL   1,758.91 (-0.28%)
AMZN   3,184.31 (+2.12%)
TSLA   563.68 (+1.49%)
NVDA   528.90 (+2.04%)
BABA   277.37 (-0.93%)
CGC   26.88 (-0.33%)
GE   10.50 (+0.48%)
MU   63.00 (-1.49%)
AMD   86.48 (+1.66%)
T   28.98 (-0.86%)
NIO   53.17 (-0.64%)
F   9.15 (-3.17%)
ACB   8.62 (-6.61%)
NFLX   481.86 (-0.21%)
GILD   59.62 (-1.05%)
BA   217.86 (-0.29%)
DIS   147.94 (-2.34%)
S&P 500   3,623.63 (-0.32%)
DOW   29,867.15 (-0.60%)
QQQ   295.60 (+0.38%)
AAPL   116.23 (+0.92%)
MSFT   213.63 (-0.11%)
FB   274.61 (-0.83%)
GOOGL   1,758.91 (-0.28%)
AMZN   3,184.31 (+2.12%)
TSLA   563.68 (+1.49%)
NVDA   528.90 (+2.04%)
BABA   277.37 (-0.93%)
CGC   26.88 (-0.33%)
GE   10.50 (+0.48%)
MU   63.00 (-1.49%)
AMD   86.48 (+1.66%)
T   28.98 (-0.86%)
NIO   53.17 (-0.64%)
F   9.15 (-3.17%)
ACB   8.62 (-6.61%)
NFLX   481.86 (-0.21%)
GILD   59.62 (-1.05%)
BA   217.86 (-0.29%)
DIS   147.94 (-2.34%)
S&P 500   3,623.63 (-0.32%)
DOW   29,867.15 (-0.60%)
QQQ   295.60 (+0.38%)
AAPL   116.23 (+0.92%)
MSFT   213.63 (-0.11%)
FB   274.61 (-0.83%)
GOOGL   1,758.91 (-0.28%)
AMZN   3,184.31 (+2.12%)
TSLA   563.68 (+1.49%)
NVDA   528.90 (+2.04%)
BABA   277.37 (-0.93%)
CGC   26.88 (-0.33%)
GE   10.50 (+0.48%)
MU   63.00 (-1.49%)
AMD   86.48 (+1.66%)
T   28.98 (-0.86%)
NIO   53.17 (-0.64%)
F   9.15 (-3.17%)
ACB   8.62 (-6.61%)
NFLX   481.86 (-0.21%)
GILD   59.62 (-1.05%)
BA   217.86 (-0.29%)
DIS   147.94 (-2.34%)
S&P 500   3,623.63 (-0.32%)
DOW   29,867.15 (-0.60%)
QQQ   295.60 (+0.38%)
AAPL   116.23 (+0.92%)
MSFT   213.63 (-0.11%)
FB   274.61 (-0.83%)
GOOGL   1,758.91 (-0.28%)
AMZN   3,184.31 (+2.12%)
TSLA   563.68 (+1.49%)
NVDA   528.90 (+2.04%)
BABA   277.37 (-0.93%)
CGC   26.88 (-0.33%)
GE   10.50 (+0.48%)
MU   63.00 (-1.49%)
AMD   86.48 (+1.66%)
T   28.98 (-0.86%)
NIO   53.17 (-0.64%)
F   9.15 (-3.17%)
ACB   8.62 (-6.61%)
NFLX   481.86 (-0.21%)
GILD   59.62 (-1.05%)
BA   217.86 (-0.29%)
DIS   147.94 (-2.34%)
Log in
OTCMKTS:OCPNY

Olympus Stock Forecast, Price & News

$20.83
+0.70 (+3.48 %)
(As of 11/24/2020 12:00 AM ET)
Add
Compare
Today's Range
$20.06
Now: $20.83▼
$21.09
50-Day Range
$18.77
MA: $20.31▼
$22.00
52-Week Range
$11.09
Now: $20.83▼
$22.10
Volume10,061 shs
Average Volume26,175 shs
Market Capitalization$28.56 billion
P/E Ratio74.39
Dividend Yield0.35%
Beta0.63
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers video endoscopy systems; gastrointestinal, colono, duodeno, and broncho endoscopes; ultrasound endoscopes and probes, endoscopic ultrasound observation devices, and capsule endoscope systems; reprocessing products for cleaning, disinfection, and sterilization of endoscopy equipment; integrated documentation system for capturing information relevant to endoscopy, therapeutic, and other ancillary equipment; endotherapy devices; endoscopy products for gastrointestinal surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology; ear, nose, and throat endoscope products; and surgical endoscope ancillary equipment. The company also provides upright, polarizing, inverted, laser scanning confocal, stereo, and macro fluorescence microscopes; box-type fluorescence imaging devices, microscope digital cameras, life science imaging software, bio-imaging systems, and virtual slide systems; metallurgical, semiconductor and flat-panel display inspection, laser scanning, and measuring microscopes; microscopic 3D measurement instruments, and industrial microscope ancillary equipment; and industrial videoscopes and fiberscopes, industrial rigidscopes and ancillary equipment, ultrasonic flaw detectors, eddy current and phased array flaw detectors, and X-ray fluorescence and X-ray diffraction analyzers. In addition, it offers interchangeable lens cameras, compact digital cameras, digital camera accessories, lens barrels units, optical components, digital audio recorders, binoculars, and related software applications. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
Read More
Olympus logo

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.19 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Structural clay products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:OCPNY
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.olympus-global.com
Phone813-3340-2111
Employees35,174

Debt

Debt-to-Equity Ratio0.78
Current Ratio1.75
Quick Ratio1.22

Price-To-Earnings

Trailing P/E Ratio74.39
Forward P/E Ratio80.12
P/E GrowthN/A

Sales & Book Value

Annual Sales$7.32 billion
Price / Sales3.90
Cash Flow$0.86 per share
Price / Cash Flow24.10
Book Value$2.51 per share
Price / Book8.30

Profitability

EPS (Most Recent Fiscal Year)$0.36
Net Income$475.36 million
Net Margins5.34%
Return on Equity10.82%
Return on Assets3.98%

Miscellaneous

Outstanding Shares1,370,915,000
Market Cap$28.56 billion
Next Earnings Date11/25/2020 (Estimated)
OptionableNot Optionable
$20.83
+0.70 (+3.48 %)
(As of 11/24/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive OCPNY News and Ratings via Email

Sign-up to receive the latest news and ratings for OCPNY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Olympus (OTCMKTS:OCPNY) Frequently Asked Questions

How has Olympus' stock price been impacted by Coronavirus?

Olympus' stock was trading at $17.6660 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, OCPNY shares have increased by 17.9% and is now trading at $20.83.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Olympus?

Wall Street analysts have given Olympus a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Olympus wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Olympus' next earnings date?

Olympus is scheduled to release its next quarterly earnings announcement on Wednesday, November 25th 2020.
View our earnings forecast for Olympus.

How were Olympus' earnings last quarter?

Olympus Co. (OTCMKTS:OCPNY) issued its quarterly earnings data on Wednesday, August, 5th. The company reported ($0.02) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.03) by $0.01. The firm earned $1.32 billion during the quarter, compared to analyst estimates of $1.29 billion. Olympus had a net margin of 5.34% and a return on equity of 10.82%.
View Olympus' earnings history.

Are investors shorting Olympus?

Olympus saw a increase in short interest in October. As of October 30th, there was short interest totaling 21,600 shares, an increase of 227.3% from the October 15th total of 6,600 shares. Based on an average daily volume of 21,700 shares, the days-to-cover ratio is presently 1.0 days.
View Olympus' Short Interest.

Who are some of Olympus' key competitors?

Some companies that are related to Olympus include AstraZeneca PLC (AZN.L) (AZN), Commonwealth Bank of Australia (CSLLY), GlaxoSmithKline (GSK), Stryker (SYK), Intuitive Surgical (ISRG), Anthem (ANTM), Zoetis (ZTS), Gilead Sciences (GILD), GlaxoSmithKline plc (GSK.L) (GSK), Becton, Dickinson and (BDX), Vertex Pharmaceuticals (VRTX), Takeda Pharmaceutical (TAK), Humana (HUM), Regeneron Pharmaceuticals (REGN) and Bayer Aktiengesellschaft (BAYRY).
View all competitors.

Who are Olympus' key executives?

Olympus' management team includes the following people:
  • Hiroyuki Tsuji, Director
  • Mr. Yasuo Takeuchi, Pres, CEO, Representative Exec. Officer & Director (Age 63)
  • Mr. Chikashi Takeda, Exec. Officer & CFO (Age 58)
  • Mr. Nacho Abia, COO & Exec. Officer (Age 52)
  • Mr. Akihiro Taguchi, CTO & Exec. Officer (Age 62)
  • Mr. Stefan Kaufmann, Chief Admin. Officer, Exec. Officer & Director (Age 52)
  • Ms. Donna Miller, Head of HQ Legal and Global Gen. Counsel
  • Ms. Caroline H. West, Chief Compliance Officer (Age 62)
  • Mr. Mark Miller, Global Chief Communications Officer
  • Shigeto Ohtsuki, Corp. Officer & HR Head

What is Olympus' stock symbol?

Olympus trades on the OTCMKTS under the ticker symbol "OCPNY."

How do I buy shares of Olympus?

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Olympus' stock price today?

One share of OCPNY stock can currently be purchased for approximately $20.83.

How big of a company is Olympus?

Olympus has a market capitalization of $28.56 billion and generates $7.32 billion in revenue each year. The company earns $475.36 million in net income (profit) each year or $0.36 on an earnings per share basis. Olympus employs 35,174 workers across the globe.

What is Olympus' official website?

The official website for Olympus is www.olympus-global.com.

How can I contact Olympus?

Olympus' mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914. The company can be reached via phone at 813-3340-2111 or via email at [email protected]

This page was last updated on 11/25/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.